Having trouble accessing articles? Reset your cache.

Thinning the uterine wall

Aromatase inhibitors are used as chronic treatments in postmenopausal women with estrogen-receptive breast cancer. But given their mechanism of action - which is to inhibit the aromatase enzyme that converts certain androgens to estrogen - Meditrina Pharmaceuticals Inc.

Read the full 384 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE